Ruby Thomas, APRN
Nurse Practitioner · Tulsa, OKNPI 1477907244
Payments from drug & device makers
Across 46 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$339
- Medtronic$335
- Collegium Pharmaceutical, Inc.$101
- Boston Scientific$51
- Biohaven Pharmaceutical Holding Company Ltd.$37
- AstraZeneca$30
- plus $161 from 8 others
What the payments were for
- Food & beverage$1,056100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 15 | $339 |
| Medtronic | 12 | $335 |
| Collegium Pharmaceutical, Inc. | 6 | $101 |
| Boston Scientific | 1 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| AstraZeneca | 1 | $30 |
| Braeburn Inc. | 1 | $28 |
| Indivior Inc. | 2 | $28 |
| SK Life Science, Inc. | 1 | $27 |
| Convatec Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| GRT US Holding, Inc. | 1 | $13 |
How this compares
$1,056 in reported general payments places this provider in the 80th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 348 | $56,954 |
| Buprenorphine Hcl | 181 | $9,273 |
| Buprenorphine | 14 | $3,650 |
| Gabapentin | 70 | $937 |
| Ibuprofen | 11 | $182 |
| Tizanidine Hcl | 19 | $154 |
| Pregabalin | 14 | $107 |
| Cyclobenzaprine Hcl | 22 | $65 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Tulsa
- Jenny GuthrieTulsa$106K
- Stacy NewberryTulsa$28K
- Amanda SmallTulsa$14K
- Mindi PriceTulsa$11K
- Huong HuynhTulsa$10K
- Jonathan BouldinTulsa$10K
- Michelle LoeberTulsa$10K
- Erin WilliamsonTulsa$9K
- Andrea CarpenterTulsa$7K
- Charles SpradlinTulsa$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.